secwatch.observer — SEC 8-K summary
======================================

Issuer:     Raphael Pharmaceutical Inc. (RAPH)
CIK:        0001415397
Form:       8-K
Filed at:   2022-10-24T23:59:59+00:00
Accession:  0001213900-22-065828
Event type: other_material
Sentiment:  positive
Materiality: 0.45
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Raphael Pharmaceutical accepted for OTCQB up-list, to trade under 'RAPH'
------------------------------------------------------------------------

- Application submitted September 1, 2022; notified of acceptance on October 7, 2022.
- Will trade on OTCQB under ticker symbol 'RAPH' after trading approval from OTC Markets.
- Company has paid required fees and increased financial transparency to meet OTCQB standards.
- Management believes the up-list better positions the company for a greater growth trajectory.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1415397/000121390022065828/0001213900-22-065828-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1415397/000121390022065828/ea167503-8k_raphael.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-065828

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer